Nazım Serdar Turhal

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer

Jane Blazeby, Thierry Conroy, Andrew Bottomley et al. · European Journal of Cancer · 2004 · 225 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +14

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

Filiz Füsun Bölükbaş, Cengiz Bölükbaş, Mahmut Gümüş et al. · BMC Cancer · 2004 · 85 citations · Full text

Medicine, Endocrinology, Oncology +15

Efficacy of treatment to relieve mucositis-induced discomfort

Nazım Serdar Turhal, Seçkin Erdal, Seray Karacay · Supportive Care in Cancer · 2000 · 60 citations · Full text

Pharmacy, Pharmacotherapy, Pain Management +10

Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer

Umut Kefeli, Faysal Dane, Perran Fulden Yumuk et al. · European Journal of Cancer Care · 2009 · 49 citations

Pharmacy, Oncology, Pharmacotherapy +17